Interprofessional Controlled Substance Risk Mitigation Initiative Symposium: An Interactive Forum Bringing Together Dentists, Physicians, Dental Hygienists, Students, and Specialists in the Field

Boston, MA •June 8, 2019 • 8:30 AM - 3:15 PM

In the past, dentists have been among the most frequent prescribers of short acting opioids, often with unused pills remaining after dental procedures. In spite of the recent, significant drop in opioid prescribing, at-risk patients are seen at all clinical practices. Practicing dentists and dentists-in-training require evidence-based, cost-effective strategies for assessing and managing their complex patients. Two thirds of practicing dentists still believe that it is not within their professional role to screen patients for substance use disorders, a fact that likely resulted in the slow adoption of prescription monitoring programs (PMPs). National data has shown that less than one third of dentists currently employ PMP data despite many states making its use mandatory. Even fewer dentists employ web-based assessment strategies, such as the NIDA Quick Screen, for assessment. A further factor is that many of the assessment and clinical management tools available to practitioners are irrelevant to dentistry. Due to improving technology and other developments, dentists now have an opportunity to employ effective alternatives to opioid analgesics for acute dental pain, and better technology for assessing and managing the complex pain patient.

Location/Venue
Tufts University School of Dental Medicine
One Kneeland Street
Boston, MA 02111
Ticket Information
For ticket information, LOG IN or SIGN UP
Course Information

In the past, dentists have been among the most frequent prescribers of short acting opioids, often with unused pills remaining after dental procedures. In spite of the recent, significant drop in opioid prescribing, at-risk patients are seen at all clinical practices. Practicing dentists and dentists-in-training require evidence-based, cost-effective strategies for assessing and managing their complex patients. Two thirds of practicing dentists still believe that it is not within their professional role to screen patients for substance use disorders, a fact that likely resulted in the slow adoption of prescription monitoring programs (PMPs). National data has shown that less than one third of dentists currently employ PMP data despite many states making its use mandatory. Even fewer dentists employ web-based assessment strategies, such as the NIDA Quick Screen, for assessment. A further factor is that many of the assessment and clinical management tools available to practitioners are irrelevant to dentistry. Due to improving technology and other developments, dentists now have an opportunity to employ effective alternatives to opioid analgesics for acute dental pain, and better technology for assessing and managing the complex pain patient.

The Controlled Substance Risk Mitigation Initiative (CSRMI) Symposium will bring together nationally recognized experts on controlled substance risk mitigation and provide practicing dentists, dental specialists and dentists-in-training with an introduction to the current state of science and best clinical practices. The program will include an interactive forum for participants to review, discuss, and provide input on the development of future evidence-based educational content.

This symposium and interactive forum will not only provide an opportunity to learn about the important work being done on behalf of the Massachusetts Governor's Working Group on Prescription Drug Misuse but will also have an impact on shaping future dental education and will put participants on the forefront of improving standards of dental practice.

Participating experts include specialists in dentistry, oral sergeants, pain medicine, pharmacy, addiction medicine, and the behavioral sciences.  

Program:

  • Introduction and Commentary with Course Director Ronald Kulich, PhD and Course Director David Keith, DMD, BDS
  • Keynote Address: Assessment and Management of Substance Use with Kevin P. Hill, MD
  • Clinical Models for Risk Mitigation in Dental Medicine with Ellen Patterson, MD, MA, and Jeffry Shaefer, DDS, MS, MPH
  • Pharmacotherapy Management of Acute Pain to Maximize Outcome and Reduce Risk with Paul A. Moore, DMD, PhD, MPH
  • Identifying Medical and Psychiatric Conditions with Substance Use Risk with Ronald J. Kulich, PhD
  • Improve Care and Minimize Risk: Standardized Strategies, Responses, and Legal Issues with David. A. Keith, DMD
  • Lunch and Exhibits
  • Concurrent Afternoon Sessions (choose one):
    • New Advances in the Management of Acute Dental Pain: Updated Principles for Rational Prescribing and Alternatives to Opioid Therapy with Steven J. Scrivani, DDS, DMSc, and discussant Richard Harold, DMD, BS in Pharmacy, JD
    • A Model for Persistent Headache and Facial Pain: Screening Approaches for Mitigating and Managing Controlled Substance Risk: Opioids, Benzodiazepines, Sedatives, Cannabis, Alcohol, and Tobacco with Micahel E. Schatman, PhD, DAAPM, and discussant Ronald J. Kulich, PhD
    • Identifying and Managing Medical and Psychiatric Conditions Associated with Increased Controlled Substance Risk with Kelly M. Wawrzyniak, PsD, and discussant David J. DeBennedetto, MD
    • Prescription Monitoring Programs for Dental Risk Management Strategies, Responses, and Legal Issues with Richard D'Innocenzo, MD, DMD, and discussant Alberto Malacarne, DDS
  • Roundtable Discussion with Experts
  • Exhibits and Reception (3:15-4:30pm)
Lodging Information
The hotels listed below are within walking distance of the Tufts University School of Dental Medicine and offer a Tufts rate to program participants. Because rates vary depending on availability, please book your room early.

Courtyard by Marriott
Boston Tremont
275 Tremont Street
Boston, MA 02116
Reservations: 800.321.2211
Phone: 617.426.1400
Fax: 617.482.6730
www.CourtyardBostonTremont.com

The DoubleTree Hotel
821 Washington Street
Boston, MA 02111
Phone: 617.956.7900
Fax: 617.956.7901
www.hiltonfamilyboston.com/downtown

The W Hotel Boston
100 Stuart Street
Boston, MA 02116
Phone: 617.261.8700
Fax: 617.310.6730
www.WHotels.com/boston
Speaker Information

David Keith, D.M.D., B.D.S.Professor, Harvard School of Dental Medicine; Department of Oral and Maxillofacial Surgery, Massachusetts General Hospital

RONALD R. KULICH, Ph.D., Professor, Craniofacial Pain, Headache, and Sleep Center, Tufts University School of Dental Medicine; Lecturer, Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Harvard Medical School


Credit Information
Tufts University School of Dental Medicine designates this activity for 5.0 continuing education credits.

 
Tufts University School of Dental Medicine is an ADA CERP Recognized Provider. Approval Date12/15-11/19. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit house by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to ADA CERP at ADA.org/goto/cerp. 
Cancellation Policy
The Division of Continuing Education reserves the right to end registration when enrollment limit is reached and to cancel, modify, or alter content or faculty for any course if circumstances indicate the need for such a change. If the school finds it necessary to cancel a course, a full refund will be granted. All attempts to contact registrants will be made as soon as possible in the event of a course cancellation. The school will not be held responsible for any losses due to travel arrangements made by the registrant.

In the event of inclement weather (such as a snow emergency) or other extenuating circumstances, the Division of Continuing Education may be forced to cancel a course. If a course has been cancelled, we will contact participants by the phone number and/or email address provided. You may call or email our office on the day of the course if you are uncertain of a course’s status.

Refunds

Full tuition refund or credit will be given for cancellations received at least two weeks prior to course date. Refunds or tuition credit will not be issued for participant no-shows.
5.0 CEU's for $150 (Doctors) / $95 for RDH, other Healthcare Providers, Educators, and Staff
FREE for Students
Registration Information
Surgical experience is not required to attend this course.
Learning Objectives
  • Distinguish risk factors associated with the initiation or maintenance of controlled substances, including but not limited to short acting opioid analgesics
  • Apply evidence-based strategies for managing the complex patient, including assessment and management of the patient at-risk for substance misuse or addiction
  • Evaluate the limitations of current risk-stratification screening in dentistry and utilize new technology for efficient screening and management of the complex pain patient
Target Audiences
GPs, Specialists